US Patent 9873694 Imidazole quinoline-based immune system modulators
Patent 9873694 was granted and assigned to Janus Biotherapeutics Inc. on January, 2018 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9873694 Imidazole quinoline-based immune system modulators
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
